ASSESSMENT TRIAL OF THE EFFECT OF SYL1001 DRUG IN PATIENTS WITH OCULAR PAI
- Conditions
- PATIENTS WITH DIAGNOSIS OF OCULAR PAIN MILD TO MODERATE AND DRY EYE MILD TO MODERATETherapeutic area: Diseases [C] - Eye Diseases [C11]
- Registration Number
- EUCTR2012-001177-93-ES
- Lead Sponsor
- Sylentis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
NA
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 30
Exclusion Criteria
NA
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ANALGESIC EFFECT AND TOLERABILITY OF SYL1001 IN PATIENTS WITH DRY EYE AND OCULAR PAIN;Secondary Objective: Ocular tolerability<br>SAE assessment<br>Analytical parameters;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA
- Secondary Outcome Measures
Name Time Method Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA